Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Sep 26, 2024
- Accession no.
- 0000950170-24-109683
- Filed
- Sep 26, 2024, 5:33 PM ET
- Trade date
- Sep 25, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 0 non-derivative transactions and 1 derivative transaction. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0000950170-24-110093 (Sep 27, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | 3.75% Convertible Notes due 2029 | PPurchaseAcquired | – | $1,571,050.00 | – | – | Indirect | Price outlier |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.